HK94496A - Compositions and their use for treating gastrointestinal disorders - Google Patents

Compositions and their use for treating gastrointestinal disorders

Info

Publication number
HK94496A
HK94496A HK94496A HK94496A HK94496A HK 94496 A HK94496 A HK 94496A HK 94496 A HK94496 A HK 94496A HK 94496 A HK94496 A HK 94496A HK 94496 A HK94496 A HK 94496A
Authority
HK
Hong Kong
Prior art keywords
bismuth
gastrointestinal disorders
agent
compositions
treating
Prior art date
Application number
HK94496A
Other languages
English (en)
Inventor
Geoffrey Place
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21816102&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK94496(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of HK94496A publication Critical patent/HK94496A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/29—Antimony or bismuth compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/345—Nitrofurans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK94496A 1987-03-09 1996-05-30 Compositions and their use for treating gastrointestinal disorders HK94496A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2359787A 1987-03-09 1987-03-09

Publications (1)

Publication Number Publication Date
HK94496A true HK94496A (en) 1996-06-07

Family

ID=21816102

Family Applications (1)

Application Number Title Priority Date Filing Date
HK94496A HK94496A (en) 1987-03-09 1996-05-30 Compositions and their use for treating gastrointestinal disorders

Country Status (12)

Country Link
US (1) US5403830A (xx)
EP (1) EP0282132B1 (xx)
JP (1) JP2648327B2 (xx)
KR (1) KR960016582B1 (xx)
AT (1) ATE81011T1 (xx)
AU (2) AU621286B2 (xx)
CA (1) CA1312013C (xx)
DE (1) DE3874917T2 (xx)
DK (1) DK175968B1 (xx)
HK (1) HK94496A (xx)
IE (1) IE62071B1 (xx)
NZ (1) NZ223773A (xx)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL85472A (en) * 1987-03-09 1991-06-30 Procter & Gamble Pharmaceutical compositions for treating gastrointestinal disorders
ATE81011T1 (de) * 1987-03-09 1992-10-15 Procter & Gamble Zusammensetzungen und ihre verwendung zur behandlung von magen-darmstoerungen.
CH679582A5 (xx) * 1988-07-18 1992-03-13 Glaxo Group Ltd
AU641903B2 (en) * 1988-10-26 1993-10-07 Glaxo Group Limited Carboxylic acid derivatives
FI910088A (fi) * 1990-01-09 1991-07-10 Gist Brocades Nv Oral farmaceutisk komposition.
GB9009437D0 (en) * 1990-04-26 1990-06-20 Glaxo Group Ltd Chemical compounds
GB9010039D0 (en) * 1990-05-03 1990-06-27 Reckitt & Colmann Prod Ltd Medicament preparation
ES2084174T3 (es) * 1990-07-20 1996-05-01 Tillotts Pharma Ag Productos y procesos para el tratamiento del conducto alimentario.
GB9019875D0 (en) * 1990-09-11 1990-10-24 Glaxo Group Ltd Pharmaceutical compositions
CA2052698A1 (en) * 1990-10-11 1992-04-12 Roger G. Berlin Treatment of peptic ulcer
US5192752A (en) * 1991-01-14 1993-03-09 The Procter & Gamble Company Swallowable pharmaceutical compositions containing colloidal bismuth subcitrate
US5128140A (en) * 1991-01-14 1992-07-07 The Procter & Gamble Company Swallowable pharmaceutical compositions
GB9120131D0 (en) * 1991-09-20 1991-11-06 Glaxo Group Ltd Medicaments
ES2130152T3 (es) * 1991-12-06 1999-07-01 Glaxo Group Ltd Medicamentos para tratar dolencias inflamatorias o para analgesia que contienen un nsaid y ranitidina/citrato de bismuto.
GB9127150D0 (en) * 1991-12-20 1992-02-19 Smithkline Beecham Plc Novel treatment
EP0642797B1 (en) * 1993-09-09 2000-05-17 Takeda Chemical Industries, Ltd. Formulation comprising antibacterial substance and antiulcer substance
BG61302B1 (bg) * 1993-09-30 1997-05-30 Нихфи Ад n-(3-(3-(1-пиперидинилметил)фенокси)пропил)хидроксиацетамид 1,2,3-пропентрикарбоксилат бисмут /3+/комплекс и метод за получаването му
US5834002A (en) * 1994-05-02 1998-11-10 Josman Laboratories, Inc. Chewing gum containing colloidal bismuth subcitrate
US6902738B2 (en) * 1994-05-02 2005-06-07 Josman Laboratories, Inc. Topical oral dosage forms containing bismuth compounds
US6426085B1 (en) 1994-05-02 2002-07-30 Josman Laboratories Inc. Use of bismuth-containing compounds in topical oral dosage forms for the treatment of halitosis
AU1671295A (en) * 1994-12-19 1996-07-10 Lauteral Limited Combinations of ranitidine hydrochloride-form 1 and bismuth compounds
US6379651B1 (en) 1995-02-07 2002-04-30 Josman Laboratories Oral-topical dosage forms for delivering antibacterials/antibiotics to oral cavity to eradicate H. pylori as a concomitant treatment for peptic ulcers and other gastro-intestinal diseases
US6372784B1 (en) 1995-02-07 2002-04-16 Josman Laboratories, Inc. Bismuth-containing compounds in topical dosage forms for treatment of corneal and dermal wounds
CA2237384A1 (en) * 1995-11-13 1997-05-22 The Albany Medical College Analgesic compounds and uses thereof
US6156771A (en) * 1997-08-28 2000-12-05 Rubin; Walter Method for alleviation of lower gastrointestinal disorders in a human patient
CA2349575A1 (en) 1998-11-17 2000-05-25 Nitromed, Inc. Nitrosated and nitrosylated h2 receptor antagonist compounds, compositions and methods of use
US6852739B1 (en) * 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
US6955099B2 (en) * 2002-07-19 2005-10-18 Goodin John W Spill proof liquid sample cup
US7211590B2 (en) * 2002-08-01 2007-05-01 Nitromed, Inc. Nitrosated proton pump inhibitors, compositions and methods of use
JP2006067124A (ja) 2004-08-25 2006-03-09 Nec Corp 画像符号化データの切り替え方法および装置、システムならびにプログラム
US20160015647A1 (en) * 2013-03-07 2016-01-21 Capsugel Belgium Nv Bismuth liquid filled hard capsules
KR101583452B1 (ko) * 2015-01-30 2016-01-11 주식회사 대웅제약 위장질환 치료용 의약 조성물

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2218883B1 (xx) * 1973-02-28 1976-08-13 Science Union & Cie
CH638975A5 (fr) * 1979-07-27 1983-10-31 Prebuilt Ets Composition medicamenteuse pour le traitement des ulceres gastro-duodenaux.
AU590578B2 (en) * 1985-04-18 1989-11-09 Procter & Gamble Company, The Treatment of non-ulcer dyspepsia with bismuth salts
EP0206626B2 (en) * 1985-06-13 2002-05-22 Barry James Dr. Marshall Use of Bismuth for the manufacture of a medicament for the treatment of gastrointestinal disorders induced by Campylobacter polyridis
ATE318144T1 (de) * 1985-06-13 2006-03-15 Barry James Marshall Pharmazeutische zusammensetzung zur behandlung gastrointestinaler beschwerden, die wismut und ein antimikrobielles mittel enthält
US4959384A (en) * 1985-10-24 1990-09-25 Norwich Eaton Pharmaceuticals, Inc. Use of nitrofurantoin for the treatment and prophylaxis of gastrointestinal disorders
ATE81011T1 (de) * 1987-03-09 1992-10-15 Procter & Gamble Zusammensetzungen und ihre verwendung zur behandlung von magen-darmstoerungen.
IL85472A (en) * 1987-03-09 1991-06-30 Procter & Gamble Pharmaceutical compositions for treating gastrointestinal disorders
AU623868B2 (en) * 1987-10-12 1992-05-28 Capability Services Pty. Limited Improved method for treatment of gastrointestinal disorders
CH679582A5 (xx) * 1988-07-18 1992-03-13 Glaxo Group Ltd

Also Published As

Publication number Publication date
AU660956B2 (en) 1995-07-13
NZ223773A (en) 1991-04-26
EP0282132B1 (en) 1992-09-30
JP2648327B2 (ja) 1997-08-27
CA1312013C (en) 1992-12-29
EP0282132A2 (en) 1988-09-14
DK175968B1 (da) 2005-10-03
US5403830A (en) 1995-04-04
DK127688A (da) 1988-09-10
IE880664L (en) 1988-09-09
JPS63290830A (ja) 1988-11-28
DE3874917T2 (de) 1993-03-04
ATE81011T1 (de) 1992-10-15
AU1279488A (en) 1988-09-08
IE62071B1 (en) 1994-12-14
DE3874917D1 (de) 1992-11-05
KR880010768A (ko) 1988-10-24
KR960016582B1 (ko) 1996-12-16
EP0282132A3 (en) 1989-11-15
DK127688D0 (da) 1988-03-09
AU1030392A (en) 1992-03-05
AU621286B2 (en) 1992-03-12

Similar Documents

Publication Publication Date Title
HK94496A (en) Compositions and their use for treating gastrointestinal disorders
EP0282131A3 (en) Compositions and methods for treating gastrointestinal disorders
CA2158475A1 (en) Composition and method for reducing toxicity of biologically-active factors
PH22614A (en) 9-amino-1,2,3,4-tetrahydroacridin-1-alpha and related compounds and their use as medicament
IL86633A (en) 2-furanone derivatives, their preparation and pharmaceutical compositions containing them
DK465488D0 (da) Farmaceutisk praeparat indeholdende en triazol-forbindelse
DE3273453D1 (en) Slip-type elevator locking mechanism
GB8704190D0 (en) Therapeutic agent
DE3369682D1 (en) 2-substituted 1-aminoalkyl-1,2,3,4-tetrahydro-beta-carbolines, their preparation and use as medicaments
CA2132544A1 (en) Angiotensin ii antagonists against disorders associated with impaired neuronal conduction velocity, especially diabetic neuropathy
DE3867086D1 (de) Benzothiepino(5,4-c)pyridazin-verbindungen und ihre pharmazeutischen wirkungen.
EP0155934A4 (en) Pharmaceutical compositions for the treatment of disorders caused by human drugs.
IL91152A0 (en) Furylthiazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL89392A0 (en) Compositions for the treatment of osteoporosis in humans comprising 24,25-dihydroxy-vitamin d3
ES267504Y (es) "herraje de inversion para el cinturon de seguridad".
IL67671A0 (en) 3-alkenyl-and-alkynyl-thio-and-amino-4-amino-6-tert.-butyl-1,2,4-triazin-5-ones,their preparation and their use as herbicides
EP0127389A3 (en) N,n-diethyl-5-methyl-2h-1-benzothiopyrano-(4,3,2-cd)-indazole-2-ethanamine, compositions comprising the same and uses therefor
IE880313L (en) Fungicidal compositions
ZA877732B (en) Halocyclopropyl compounds,their preparation and their use as herbicides
IT8719184A0 (it) Gastroduodenale. composizioni farmaceutiche ad azione sinergica antisecretoria per la cicatrizzazione dell'ulcera
ZA816799B (en) Pharmaceutical compositions for the treatment of gastric hyperacidity,gastritis and gastro-duodenal ulcers
EP0116637A4 (en) N-ALKYL-4'-HYDROXYACETANILIDE, MEDICINAL COMPOSITIONS THAT CONTAIN AND USE THEREOF.

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20080301